Manufacturing News of Note—Dr. Reddy's to have CDMOs produce some of its drugs in China

stocks
(Pixabay)

> Teva Pharmaceutical's plant in in Kfar Saba, Israel, has been approved to produce its new migraine treatment Ajovy. Story

> Dr. Reddy's is using contractors in China for production of some of its products. Story

> CDMO WuXi STA will handle development and production of cancer drugs for Chinese biotech Impact Therapeutics. Release

> The European Medicines Agency has cited Indian antibiotic producer Acharya Chemicals for a variety of GMP violations. Filing 

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.